Azacitidine Injection
Generic name: Pronounced as (ay za site' i deen)
Medical Content Reviewed By HelloPharmacist Staff
Last Revised - 11/01/2007
On this page
- Why is this medication prescribed?
- How should this medicine be used?
- Other uses for this medicine
- What special precautions should I follow?
- What special dietary instructions should I follow?
- What should I do if I forget a dose?
- What side effects can this medication cause?
- What should I know about STORAGE and DISPOSAL of this medication?
- What should I do in case of OVERDOSE?
- What OTHER INFORMATION should I know?
- Other names
- Drug interactions
Why is this medication prescribed?
Azacitidine is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and does not produce enough healthy blood cells). Azacitidine is in a class of medications called demethylation agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells in the bone marrow.
How should this medicine be used?
Azacitidine comes as a powder to be mixed with water and injected subcutaneously (under the skin) or intravenously (into a vein) by a doctor or nurse in a medical office or hospital outpatient department. It is usually injected once a day for 7 days. This treatment may be repeated every 4 weeks for as long as your doctor recommends. Treatment should usually be given for at least four cycles.
Your doctor may increase your dose of azacitidine after two cycles if your condition has not improved and if you have not experienced serious side effects of the medication. Your doctor may also need to delay your treatment or reduce your dose if you experience certain side effects. Be sure to tell your doctor how you are feeling during your treatment with azacitadine.
Your doctor will give you medication to prevent nausea and vomiting before you receive each dose of azacitadine.
Other uses for this medicine
This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before using azacitidine,
-
tell your doctor and pharmacist if you are allergic to azacitidine, mannitol (Osmitrol, Resectisol), or any other medications.
-
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor if you have a liver tumor. Your doctor may tell you not to take azacitidine.
-
tell your doctor if you have or have ever had liver or kidney disease.
-
tell your doctor if you are pregnant or plan to become pregnant, or if you plan to father a child. You or your partner should not become pregnant while you are using azacitidine. You should use birth control to prevent pregnancy in yourself or your partner during your treatment with azacitidine. Talk to your doctor about birth control methods that will work for you. If you or your partner become pregnant while using azacitidine, call your doctor. Azacitidine may harm the fetus.
-
do not breastfeed while you are using azacitidine.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are using azacitidine.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Call your doctor right away if you are unable to keep an appointment to receive a dose of azacitidine.
What side effects can this medication cause?
-
Azacitidine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
nausea
-
vomiting
-
diarrhea
-
constipation
-
sores on the mouth or tongue
-
hemorrhoids
-
stomach pain or tenderness
-
heartburn
-
loss of appetite
-
weight loss
-
headache
-
dizziness
-
weakness
-
excessive tiredness
-
difficulty falling asleep or staying asleep
-
depression
-
anxiety
-
back, muscle, or joint pain
-
muscle cramps
-
sweating
-
night sweats
-
difficulty urinating or pain when urinating
-
swelling of the hands, feet, ankles, or lower legs
-
dry skin
-
redness, pain, bruising, swelling, itching, lump, or change in the skin color in the place where the medication was injected
-
-
Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:
-
pale skin
-
shortness of breath
-
fast heartbeat
-
chest pain
-
cough
-
unusual bruising or bleeding
-
nosebleeds
-
bleeding gums
-
small red or purple dots on the skin
-
sore throat, fever, chills, or other signs of infection
-
hives
-
rash
-
itching
-
difficulty breathing or swallowing
-
-
Azacitidine may cause other side effects. Call your doctor if you have any unusual problems while using this medication.
What should I know about STORAGE and DISPOSAL of this medication?
This medication will be stored in the medical office or hospital where you receive your treatment.
What should I do in case of OVERDOSE?
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include:
-
diarrhea
-
nausea
-
vomiting
What OTHER INFORMATION should I know?
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to azacitidine.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Drug interactions
Drug | Interaction |
---|---|
Leflunomide | Leflunomide The risk or severity of adverse effects can be increased when Azacitidine is combined with Leflunomide. |
Anagrelide | Anagrelide The risk or severity of bleeding can be increased when Anagrelide is combined with Azacitidine. |
Cilostazol | Cilostazol Azacitidine may decrease the excretion rate of Cilostazol which could result in a higher serum level. |
Clopidogrel | Clopidogrel The risk or severity of bleeding can be increased when Clopidogrel is combined with Azacitidine. |
Estrogen and Progestin (Oral Contraceptives) | Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Fenofibrate | Fenofibrate Azacitidine may decrease the excretion rate of Fenofibrate which could result in a higher serum level. |
Guanfacine | Guanfacine Azacitidine may decrease the excretion rate of Guanfacine which could result in a higher serum level. |
Magnesium Hydroxide | Magnesium Hydroxide Azacitidine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level. |
Mycophenolate | Mycophenolate The risk or severity of adverse effects can be increased when Azacitidine is combined with Mycophenolic acid. |
Olsalazine | Olsalazine Olsalazine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Potassium | Potassium Potassium may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Prednisone | Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Azacitidine. |
Ranitidine | Ranitidine Ranitidine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Reserpine | Reserpine Reserpine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Rizatriptan | Rizatriptan Azacitidine may decrease the excretion rate of Rizatriptan which could result in a higher serum level. |
Sumatriptan | Sumatriptan Sumatriptan may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tacrolimus | Tacrolimus Tacrolimus may increase the immunosuppressive activities of Azacitidine. |
Triamcinolone | Triamcinolone The risk or severity of adverse effects can be increased when Triamcinolone is combined with Azacitidine. |
Ampicillin Injection | Ampicillin Injection Ampicillin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Doxycycline Injection | Doxycycline Injection Doxycycline may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Fluconazole Injection | Fluconazole Injection Fluconazole may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Foscarnet Injection | Foscarnet Injection Foscarnet may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Hydromorphone Injection | Hydromorphone Injection Hydromorphone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Interferon Beta-1b Injection | Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Azacitidine. |
Interferon Gamma-1b Injection | Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Azacitidine. |
Levofloxacin Injection | Levofloxacin Injection Azacitidine may decrease the excretion rate of Levofloxacin which could result in a higher serum level. |
Meperidine Injection | Meperidine Injection Meperidine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Methylprednisolone Injection | Methylprednisolone Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Methylprednisolone. |
Metoclopramide Injection | Metoclopramide Injection Azacitidine may decrease the excretion rate of Metoclopramide which could result in a higher serum level. |
Pamidronate Injection | Pamidronate Injection Pamidronic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Vancomycin Injection | Vancomycin Injection Azacitidine may decrease the excretion rate of Vancomycin which could result in a higher serum level. |
Zidovudine Injection | Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Azacitidine. |
Altretamine | Altretamine Amphetamine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefuroxime | Cefuroxime Cefuroxime may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cyclosporine | Cyclosporine Azacitidine may increase the immunosuppressive activities of Cyclosporine. |
Enoxaparin Injection | Enoxaparin Injection The risk or severity of bleeding can be increased when Enoxaparin is combined with Azacitidine. |
Torsemide | Torsemide Torasemide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Hydroxychloroquine | Hydroxychloroquine The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydroxychloroquine. |
Meloxicam | Meloxicam Meloxicam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Pantoprazole | Pantoprazole Pantoprazole may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Temozolomide | Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Azacitidine. |
Zaleplon | Zaleplon Azacitidine may decrease the excretion rate of Zaleplon which could result in a higher serum level. |
Anakinra | Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Azacitidine. |
Linezolid | Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Azacitidine. |
Pentosan Polysulfate | Pentosan Polysulfate The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Azacitidine. |
Etanercept Injection | Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Azacitidine. |
Perindopril | Perindopril Perindopril may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tenofovir | Tenofovir Tenofovir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Choline Magnesium Trisalicylate | Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Sirolimus | Sirolimus The risk or severity of adverse effects can be increased when Sirolimus is combined with Azacitidine. |
Epirubicin | Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Azacitidine. |
Eplerenone | Eplerenone Eplerenone may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Zonisamide | Zonisamide Zonisamide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Adalimumab Injection | Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Azacitidine. |
Atomoxetine | Atomoxetine Atomoxetine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Glatiramer Injection | Glatiramer Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Glatiramer. |
Atazanavir | Atazanavir Atazanavir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Almotriptan | Almotriptan Almotriptan may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Emtricitabine | Emtricitabine Emtricitabine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Memantine | Memantine Azacitidine may decrease the excretion rate of Memantine which could result in a higher serum level. |
Tadalafil | Tadalafil Tadalafil may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Darbepoetin Alfa Injection | Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Azacitidine. |
Infliximab Injection | Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Azacitidine. |
Duloxetine | Duloxetine Duloxetine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tinidazole | Tinidazole Tinidazole may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefditoren | Cefditoren Cefdinir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Natalizumab Injection | Natalizumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Natalizumab. |
Cyanocobalamin Injection | Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Eszopiclone | Eszopiclone Eszopiclone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ganciclovir | Ganciclovir Azacitidine may decrease the excretion rate of Ganciclovir which could result in a higher serum level. |
Palifermin | Palifermin The therapeutic efficacy of Palifermin can be decreased when used in combination with Azacitidine. |
Ribavirin | Ribavirin Ribavirin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Valganciclovir | Valganciclovir Azacitidine may decrease the excretion rate of Valganciclovir which could result in a higher serum level. |
Adefovir | Adefovir Adefovir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Dextroamphetamine | Dextroamphetamine Amphetamine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Peginterferon Alfa-2a Injection | Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Azacitidine. |
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Azacitidine. |
Ramelteon | Ramelteon Azacitidine may decrease the excretion rate of Ramelteon which could result in a higher serum level. |
Fentanyl | Fentanyl Fentanyl may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Pregabalin | Pregabalin Pregabalin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ranolazine | Ranolazine Ranolazine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Abatacept Injection | Abatacept Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Abatacept. |
Rasagiline | Rasagiline Azacitidine may decrease the excretion rate of Rasagiline which could result in a higher serum level. |
Imatinib | Imatinib The risk or severity of adverse effects can be increased when Imatinib is combined with Azacitidine. |
Sitagliptin | Sitagliptin Azacitidine may decrease the excretion rate of Sitagliptin which could result in a higher serum level. |
Varenicline | Varenicline Azacitidine may decrease the excretion rate of Varenicline which could result in a higher serum level. |
Bevacizumab Injection | Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Azacitidine. |
Albuterol | Albuterol Azacitidine may decrease the excretion rate of Salbutamol which could result in a higher serum level. |
Paliperidone | Paliperidone Azacitidine may decrease the excretion rate of Paliperidone which could result in a higher serum level. |
Bortezomib | Bortezomib The risk or severity of adverse effects can be increased when Bortezomib is combined with Azacitidine. |
Clofarabine Injection | Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Azacitidine. |
Hepatitis B Vaccine | Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Azacitidine. |
Influenza Vaccine, Inactivated or Recombinant | Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Azacitidine. |
Influenza Vaccine, Live Intranasal | Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Azacitidine. |
Live Shingles (Zoster) Vaccine (ZVL) | Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Azacitidine. |
Lubiprostone | Lubiprostone Azacitidine may decrease the excretion rate of Lubiprostone which could result in a higher serum level. |
Oxaliplatin Injection | Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Azacitidine. |
Rituximab Injection | Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Azacitidine. |
Pemetrexed Injection | Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Azacitidine. |
Vorinostat | Vorinostat The risk or severity of adverse effects can be increased when Azacitidine is combined with Vorinostat. |
Sorafenib | Sorafenib The risk or severity of adverse effects can be increased when Sorafenib is combined with Azacitidine. |
Sunitinib | Sunitinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Sunitinib. |
Levocetirizine | Levocetirizine Azacitidine may decrease the excretion rate of Levocetirizine which could result in a higher serum level. |
Pegaptanib Injection | Pegaptanib Injection Azacitidine may decrease the excretion rate of Pegaptanib which could result in a higher serum level. |
Dasatinib | Dasatinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Dasatinib. |
Temsirolimus | Temsirolimus The risk or severity of adverse effects can be increased when Azacitidine is combined with Temsirolimus. |
Nelarabine Injection | Nelarabine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Nelarabine. |
Lenalidomide | Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Azacitidine. |
Nilotinib | Nilotinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Nilotinib. |
Bexarotene | Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Azacitidine. |
Budesonide | Budesonide The risk or severity of adverse effects can be increased when Azacitidine is combined with Budesonide. |
Chloramphenicol Injection | Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Azacitidine. |
Decitabine Injection | Decitabine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Decitabine. |
Desmopressin | Desmopressin Desmopressin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Doripenem Injection | Doripenem Injection Azacitidine may decrease the excretion rate of Doripenem which could result in a higher serum level. |
Arsenic Trioxide Injection | Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Arsenic trioxide. |
Mitoxantrone Injection | Mitoxantrone Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Mitoxantrone. |
Desvenlafaxine | Desvenlafaxine Azacitidine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level. |
Cevimeline | Cevimeline Cevimeline may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tretinoin | Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Azacitidine. |
Bendamustine Injection | Bendamustine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Bendamustine. |
Certolizumab Injection | Certolizumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Certolizumab pegol. |
Ixabepilone Injection | Ixabepilone Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Ixabepilone. |
Irinotecan Injection | Irinotecan Injection The risk or severity of adverse effects can be increased when Irinotecan is combined with Azacitidine. |
Daptomycin Injection | Daptomycin Injection Daptomycin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Estramustine | Estramustine The risk or severity of adverse effects can be increased when Azacitidine is combined with Estramustine. |
Methylnaltrexone Injection | Methylnaltrexone Injection Azacitidine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level. |
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) | Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Azacitidine. |
Midazolam | Midazolam Midazolam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Dexrazoxane Injection | Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Azacitidine. |
Ibritumomab Injection | Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Azacitidine. |
Milnacipran | Milnacipran Azacitidine may decrease the excretion rate of Milnacipran which could result in a higher serum level. |
Plerixafor Injection | Plerixafor Injection Azacitidine may decrease the excretion rate of Plerixafor which could result in a higher serum level. |
Fesoterodine | Fesoterodine Azacitidine may decrease the excretion rate of Fesoterodine which could result in a higher serum level. |
Prasugrel | Prasugrel Azacitidine may decrease the excretion rate of Prasugrel which could result in a higher serum level. |
Everolimus | Everolimus The risk or severity of adverse effects can be increased when Azacitidine is combined with Everolimus. |
Tolvaptan (low blood sodium) | Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Pralatrexate Injection | Pralatrexate Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Pralatrexate. |
Palonosetron Injection | Palonosetron Injection Palonosetron may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Saxagliptin | Saxagliptin Azacitidine may decrease the excretion rate of Saxagliptin which could result in a higher serum level. |
Telavancin Injection | Telavancin Injection Azacitidine may decrease the excretion rate of Telavancin which could result in a higher serum level. |
Topotecan | Topotecan The risk or severity of adverse effects can be increased when Azacitidine is combined with Topotecan. |
Golimumab Injection | Golimumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Golimumab. |
Pazopanib | Pazopanib The risk or severity of adverse effects can be increased when Azacitidine is combined with Pazopanib. |
Denosumab Injection | Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Azacitidine. |
Dabigatran | Dabigatran The risk or severity of bleeding can be increased when Dabigatran is combined with Azacitidine. |
Tocilizumab Injection | Tocilizumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Tocilizumab. |
Dalfampridine | Dalfampridine Azacitidine may decrease the excretion rate of Dalfampridine which could result in a higher serum level. |
Fingolimod | Fingolimod Azacitidine may increase the immunosuppressive activities of Fingolimod. |
Eribulin Injection | Eribulin Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Eribulin. |
Cabazitaxel Injection | Cabazitaxel Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Cabazitaxel. |
Ceftaroline Injection | Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Acetaminophen Injection | Acetaminophen Injection Acetaminophen may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ipilimumab Injection | Ipilimumab Injection Azacitidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level. |
Denileukin Diftitox Injection | Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Azacitidine. |
Sipuleucel-T Injection | Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Azacitidine. |
Terbutaline Injection | Terbutaline Injection Terbutaline may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Belimumab Injection | Belimumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Belimumab. |
Busulfan Injection | Busulfan Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Busulfan. |
Roflumilast | Roflumilast Roflumilast may increase the immunosuppressive activities of Azacitidine. |
Cyclophosphamide Injection | Cyclophosphamide Injection The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Azacitidine. |
Rivaroxaban | Rivaroxaban Azacitidine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level. |
Ticagrelor | Ticagrelor The risk or severity of bleeding can be increased when Ticagrelor is combined with Azacitidine. |
Brentuximab Vedotin Injection | Brentuximab Vedotin Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Brentuximab vedotin. |
Ruxolitinib | Ruxolitinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Ruxolitinib. |
Clobazam | Clobazam Clobazam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Belatacept Injection | Belatacept Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Belatacept. |
Basiliximab Injection | Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Azacitidine. |
Deferiprone | Deferiprone Azacitidine may decrease the excretion rate of Deferiprone which could result in a higher serum level. |
Melphalan Injection | Melphalan Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Melphalan. |
Naloxone Injection | Naloxone Injection Azacitidine may decrease the excretion rate of Naloxone which could result in a higher serum level. |
Eculizumab Injection | Eculizumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Eculizumab. |
Fondaparinux Injection | Fondaparinux Injection Fondaparinux may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Carfilzomib Injection | Carfilzomib Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Carfilzomib. |
Iloprost | Iloprost The risk or severity of bleeding can be increased when Iloprost is combined with Azacitidine. |
Enzalutamide | Enzalutamide Azacitidine may decrease the excretion rate of Enzalutamide which could result in a higher serum level. |
Mirabegron | Mirabegron Azacitidine may decrease the excretion rate of Mirabegron which could result in a higher serum level. |
Bosutinib | Bosutinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Bosutinib. |
Corticotropin, Repository Injection | Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Corticotropin. |
Teriflunomide | Teriflunomide The risk or severity of adverse effects can be increased when Azacitidine is combined with Teriflunomide. |
Teduglutide Injection | Teduglutide Injection Azacitidine may decrease the excretion rate of Teduglutide which could result in a higher serum level. |
Icosapent Ethyl | Icosapent Ethyl The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Azacitidine. |
Tofacitinib | Tofacitinib Azacitidine may increase the immunosuppressive activities of Tofacitinib. |
Alogliptin | Alogliptin Azacitidine may decrease the excretion rate of Alogliptin which could result in a higher serum level. |
Dimethyl Fumarate | Dimethyl Fumarate The risk or severity of adverse effects can be increased when Azacitidine is combined with Dimethyl fumarate. |
Ponatinib | Ponatinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Ponatinib. |
Pomalidomide | Pomalidomide The risk or severity of adverse effects can be increased when Azacitidine is combined with Pomalidomide. |
Ado-trastuzumab Emtansine Injection | Ado-trastuzumab Emtansine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Trastuzumab emtansine. |
Apixaban | Apixaban The risk or severity of bleeding can be increased when Apixaban is combined with Azacitidine. |
Canagliflozin | Canagliflozin Azacitidine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy. |
Methazolamide | Methazolamide Methazolamide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Trametinib | Trametinib Azacitidine may decrease the excretion rate of Trametinib which could result in a higher serum level. |
Levomilnacipran | Levomilnacipran Azacitidine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level. |
Ertapenem Injection | Ertapenem Injection Ertapenem may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Vortioxetine | Vortioxetine Azacitidine may decrease the excretion rate of Vortioxetine which could result in a higher serum level. |
Ibrutinib | Ibrutinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Ibrutinib. |
Ketorolac Injection | Ketorolac Injection Ketorolac may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Obinutuzumab Injection | Obinutuzumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Obinutuzumab. |
Sofosbuvir | Sofosbuvir Azacitidine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level. |
Dapagliflozin | Dapagliflozin Dapagliflozin may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Apremilast | Apremilast The risk or severity of adverse effects can be increased when Azacitidine is combined with Apremilast. |
Droxidopa | Droxidopa Azacitidine may decrease the excretion rate of Droxidopa which could result in a higher serum level. |
Siltuximab Injection | Siltuximab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Siltuximab. |
Vedolizumab Injection | Vedolizumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Vedolizumab. |
Belinostat Injection | Belinostat Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Belinostat. |
Idelalisib | Idelalisib The risk or severity of adverse effects can be increased when Azacitidine is combined with Idelalisib. |
Testosterone Injection | Testosterone Injection Testosterone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Vorapaxar | Vorapaxar The risk or severity of bleeding can be increased when Vorapaxar is combined with Azacitidine. |
Edoxaban | Edoxaban Azacitidine may decrease the excretion rate of Edoxaban which could result in a higher serum level. |
Peginterferon Beta-1a Injection | Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Peginterferon beta-1a. |
Olaparib | Olaparib The risk or severity of adverse effects can be increased when Azacitidine is combined with Olaparib. |
Blinatumomab Injection | Blinatumomab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Blinatumomab. |
Methamphetamine | Methamphetamine Azacitidine may decrease the excretion rate of Metamfetamine which could result in a higher serum level. |
Tasimelteon | Tasimelteon Azacitidine may decrease the excretion rate of Tasimelteon which could result in a higher serum level. |
Pirfenidone | Pirfenidone The risk or severity of adverse effects can be increased when Azacitidine is combined with Pirfenidone. |
Secukinumab Injection | Secukinumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Secukinumab. |
Palbociclib | Palbociclib The risk or severity of adverse effects can be increased when Azacitidine is combined with Palbociclib. |
Panobinostat | Panobinostat The risk or severity of adverse effects can be increased when Azacitidine is combined with Panobinostat. |
Dinutuximab Injection | Dinutuximab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Dinutuximab. |
Haloperidol Injection | Haloperidol Injection Haloperidol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Amiloride | Amiloride Amiloride may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Macitentan | Macitentan Azacitidine may decrease the excretion rate of Macitentan which could result in a higher serum level. |
Prednisolone | Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Azacitidine. |
Penicillin G Procaine Injection | Penicillin G Procaine Injection Azacitidine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level. |
Mepolizumab Injection | Mepolizumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Mepolizumab. |
Trabectedin Injection | Trabectedin Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Trabectedin. |
Ixazomib | Ixazomib Azacitidine may decrease the excretion rate of Ixazomib which could result in a higher serum level. |
Lesinurad | Lesinurad Azacitidine may decrease the excretion rate of Lesinurad which could result in a higher serum level. |
Amphotericin B Liposomal Injection | Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Dexamethasone Injection | Dexamethasone Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Dexamethasone. |
Defibrotide Injection | Defibrotide Injection The risk or severity of bleeding can be increased when Defibrotide is combined with Azacitidine. |
Ixekizumab Injection | Ixekizumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Ixekizumab. |
Brivaracetam Injection | Brivaracetam Injection Azacitidine may decrease the excretion rate of Brivaracetam which could result in a higher serum level. |
Furosemide Injection | Furosemide Injection Furosemide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Lixisenatide Injection | Lixisenatide Injection Azacitidine may decrease the excretion rate of Lixisenatide which could result in a higher serum level. |
Brodalumab Injection | Brodalumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Brodalumab. |
Doxepin (Insomnia) | Doxepin (Insomnia) Azacitidine may decrease the excretion rate of Doxepin which could result in a higher serum level. |
Deutetrabenazine | Deutetrabenazine Azacitidine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level. |
Valbenazine | Valbenazine Azacitidine may decrease the excretion rate of Valbenazine which could result in a higher serum level. |
Deflazacort | Deflazacort The risk or severity of adverse effects can be increased when Azacitidine is combined with Deflazacort. |
Ocrelizumab Injection | Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Azacitidine. |
Naldemedine | Naldemedine Azacitidine may decrease the excretion rate of Naldemedine which could result in a higher serum level. |
Sarilumab Injection | Sarilumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Sarilumab. |
Guselkumab Injection | Guselkumab Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Guselkumab. |
Benznidazole | Benznidazole Azacitidine may decrease the excretion rate of Benznidazole which could result in a higher serum level. |
Delafloxacin | Delafloxacin Azacitidine may decrease the excretion rate of Delafloxacin which could result in a higher serum level. |
Betrixaban | Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Azacitidine. |
Gemtuzumab Ozogamicin Injection | Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Azacitidine. |
Ertugliflozin | Ertugliflozin Ertugliflozin may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Apalutamide | Apalutamide Azacitidine may decrease the excretion rate of Apalutamide which could result in a higher serum level. |
Penicillamine | Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Azacitidine. |
Baricitinib | Baricitinib The risk or severity of adverse effects can be increased when Azacitidine is combined with Baricitinib. |
Lofexidine | Lofexidine Azacitidine may decrease the excretion rate of Lofexidine which could result in a higher serum level. |
Plazomicin Injection | Plazomicin Injection Azacitidine may decrease the excretion rate of Plazomicin which could result in a higher serum level. |
Stiripentol | Stiripentol Azacitidine may decrease the excretion rate of Stiripentol which could result in a higher serum level. |
Methoxy Polyethylene Glycol-Epoetin Beta Injection | Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Azacitidine. |
Paclitaxel (with albumin) Injection | Paclitaxel (with albumin) Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Paclitaxel. |
Prucalopride | Prucalopride Azacitidine may decrease the excretion rate of Prucalopride which could result in a higher serum level. |
Ravulizumab-cwvz Injection | Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Ravulizumab. |
Emapalumab-lzsg Injection | Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Emapalumab. |
Siponimod | Siponimod The risk or severity of adverse effects can be increased when Azacitidine is combined with Siponimod. |
Acyclovir Ophthalmic | Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Caplacizumab-yhdp Injection | Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Caplacizumab is combined with Azacitidine. |
Risankizumab-rzaa Injection | Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Risankizumab. |
Cladribine | Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Azacitidine. |
Solriamfetol | Solriamfetol Azacitidine may decrease the excretion rate of Solriamfetol which could result in a higher serum level. |
Pitolisant | Pitolisant Azacitidine may decrease the excretion rate of Pitolisant which could result in a higher serum level. |
Ozanimod | Ozanimod The risk or severity of adverse effects can be increased when Azacitidine is combined with Ozanimod. |
Progestin-Only (drospirenone) Oral Contraceptives | Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Viloxazine | Viloxazine Azacitidine may decrease the excretion rate of Viloxazine which could result in a higher serum level. |
Tobramycin Injection | Tobramycin Injection Tobramycin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Fenoprofen | Fenoprofen Fenoprofen may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Indomethacin | Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Azacitidine. |
Mefenamic Acid | Mefenamic Acid Mefenamic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Naproxen | Naproxen Naproxen may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tolmetin | Tolmetin Tolmetin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Sulindac | Sulindac Sulindac may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Isotretinoin | Isotretinoin Azacitidine may decrease the excretion rate of Isotretinoin which could result in a higher serum level. |
Sucralfate | Sucralfate Sucralfate may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Hydroxyurea | Hydroxyurea The risk or severity of adverse effects can be increased when Azacitidine is combined with Hydroxyurea. |
Floxuridine | Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Azacitidine. |
Metaxalone | Metaxalone Metaxalone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Methotrexate Injection | Methotrexate Injection The risk or severity of adverse effects can be increased when Methotrexate is combined with Azacitidine. |
Chlorpromazine | Chlorpromazine Chlorpromazine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Diazepam | Diazepam Diazepam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Oxazepam | Oxazepam Oxazepam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Flurazepam | Flurazepam Flurazepam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Clorazepate | Clorazepate Clorazepic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Lorazepam | Lorazepam Lorazepam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Carmustine | Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Azacitidine. |
Amantadine | Amantadine Amantadine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Codeine | Codeine Codeine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Phenelzine | Phenelzine Phenelzine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Procarbazine | Procarbazine The risk or severity of adverse effects can be increased when Azacitidine is combined with Procarbazine. |
Tetracycline | Tetracycline Tetracycline may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Thioguanine | Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Azacitidine. |
Bleomycin | Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Azacitidine. |
Sulfadiazine | Sulfadiazine Sulfadiazine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Methadone | Methadone Methadone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Benztropine | Benztropine Benzatropine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Maprotiline | Maprotiline Azacitidine may decrease the excretion rate of Maprotiline which could result in a higher serum level. |
Ibuprofen | Ibuprofen Ibuprofen may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Azathioprine | Azathioprine The risk or severity of adverse effects can be increased when Azacitidine is combined with Azathioprine. |
Methylphenidate | Methylphenidate Methylphenidate may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Sulfasalazine | Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Azacitidine. |
Lomustine | Lomustine The risk or severity of adverse effects can be increased when Azacitidine is combined with Lomustine. |
Doxorubicin | Doxorubicin The risk or severity of adverse effects can be increased when Azacitidine is combined with Doxorubicin. |
Cytarabine | Cytarabine The risk or severity of adverse effects can be increased when Azacitidine is combined with Cytarabine. |
Mechlorethamine | Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Azacitidine. |
Dactinomycin | Dactinomycin The risk or severity of adverse effects can be increased when Azacitidine is combined with Dactinomycin. |
Phenazopyridine | Phenazopyridine Phenazopyridine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Carbamazepine | Carbamazepine The risk or severity of adverse effects can be increased when Carbamazepine is combined with Azacitidine. |
Methyldopa | Methyldopa Azacitidine may decrease the excretion rate of Methyldopa which could result in a higher serum level. |
Hydralazine | Hydralazine Azacitidine may decrease the excretion rate of Hydralazine which could result in a higher serum level. |
Cimetidine | Cimetidine Cimetidine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Gentamicin Injection | Gentamicin Injection Gentamicin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Warfarin | Warfarin Azacitidine may decrease the excretion rate of Warfarin which could result in a higher serum level. |
Clonazepam | Clonazepam Azacitidine may decrease the excretion rate of Clonazepam which could result in a higher serum level. |
Promethazine | Promethazine Azacitidine may decrease the excretion rate of Promethazine which could result in a higher serum level. |
Meclofenamate | Meclofenamate Meclofenamic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Daunorubicin | Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Azacitidine. |
Nitrofurantoin | Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Digoxin | Digoxin Azacitidine may decrease the excretion rate of Digoxin which could result in a higher serum level. |
Chloroquine | Chloroquine Chloroquine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Triamterene | Triamterene Triamterene may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Sulfinpyrazone | Sulfinpyrazone The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Azacitidine. |
Chlorothiazide | Chlorothiazide Chlorothiazide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Chlorthalidone | Chlorthalidone Chlorthalidone may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Metolazone | Metolazone Metolazone may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Isosorbide | Isosorbide Isosorbide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Secobarbital | Secobarbital Secobarbital may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Desipramine | Desipramine Azacitidine may decrease the excretion rate of Desipramine which could result in a higher serum level. |
Amitriptyline | Amitriptyline Amitriptyline may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Imipramine | Imipramine Imipramine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Probenecid | Probenecid Azacitidine may decrease the excretion rate of Probenecid which could result in a higher serum level. |
Quinidine | Quinidine Azacitidine may decrease the excretion rate of Quinidine which could result in a higher serum level. |
Procainamide | Procainamide Azacitidine may decrease the excretion rate of Procainamide which could result in a higher serum level. |
Isoniazid | Isoniazid Azacitidine may decrease the excretion rate of Isoniazid which could result in a higher serum level. |
Pyrazinamide | Pyrazinamide Pyrazinamide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Disopyramide | Disopyramide Disopyramide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Mitomycin | Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Azacitidine. |
Butabarbital | Butabarbital Butabarbital may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Liothyronine | Liothyronine Liothyronine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Methimazole | Methimazole The risk or severity of adverse effects can be increased when Methimazole is combined with Azacitidine. |
Propylthiouracil | Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Azacitidine. |
Chlorpropamide | Chlorpropamide Chlorpropamide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tolbutamide | Tolbutamide Azacitidine may decrease the excretion rate of Tolbutamide which could result in a higher serum level. |
Tolazamide | Tolazamide Tolazamide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Baclofen | Baclofen Baclofen may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ethambutol | Ethambutol Ethambutol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Methyclothiazide | Methyclothiazide Methyclothiazide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Hydrochlorothiazide | Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Chlorzoxazone | Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Pyridoxine | Pyridoxine Pyridoxine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Folic Acid | Folic Acid Folic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Propranolol (Cardiovascular) | Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Spironolactone | Spironolactone Spironolactone may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Amphotericin B Injection | Amphotericin B Injection Amphotericin B may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Mercaptopurine | Mercaptopurine The risk or severity of adverse effects can be increased when Azacitidine is combined with Mercaptopurine. |
Phytonadione | Phytonadione Azacitidine may decrease the excretion rate of Phylloquinone which could result in a higher serum level. |
Amikacin Injection | Amikacin Injection Amikacin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Nadolol | Nadolol Azacitidine may decrease the excretion rate of Nadolol which could result in a higher serum level. |
Allopurinol | Allopurinol The risk or severity of adverse effects can be increased when Allopurinol is combined with Azacitidine. |
Flavoxate | Flavoxate Azacitidine may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
Fluorouracil Injection | Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Azacitidine. |
Colchicine | Colchicine The risk or severity of adverse effects can be increased when Azacitidine is combined with Colchicine. |
Cefaclor | Cefaclor Cefaclor may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefadroxil | Cefadroxil Cefadroxil may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefazolin Injection | Cefazolin Injection Cefazolin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cephalexin | Cephalexin Cephalexin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefoxitin Injection | Cefoxitin Injection Cefoxitin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Dacarbazine | Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Azacitidine. |
Acetazolamide | Acetazolamide Acetazolamide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Cefotaxime Injection | Cefotaxime Injection Cefotaxime may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Calcitonin Salmon Injection | Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Bacillus Calmette-Guerin (BCG) Vaccine | Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Azacitidine. |
Pyrantel | Pyrantel Azacitidine may decrease the excretion rate of Pyrantel which could result in a higher serum level. |
Thiotepa Injection | Thiotepa Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Thiotepa. |
Vincristine Injection | Vincristine Injection The risk or severity of adverse effects can be increased when Vincristine is combined with Azacitidine. |
Dipyridamole | Dipyridamole The risk or severity of bleeding can be increased when Dipyridamole is combined with Azacitidine. |
Vinblastine | Vinblastine The risk or severity of adverse effects can be increased when Vinblastine is combined with Azacitidine. |
Ethacrynic Acid | Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Colistimethate Injection | Colistimethate Injection Colistimethate may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Metoprolol | Metoprolol Metoprolol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Aspirin | Aspirin Acetylsalicylic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Salsalate | Salsalate Salsalate may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Chlorambucil | Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Azacitidine. |
Alprazolam | Alprazolam Alprazolam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Temazepam | Temazepam Temazepam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Triazolam | Triazolam Triazolam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Dicyclomine | Dicyclomine Dicyclomine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Propantheline | Propantheline Propantheline may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Trimethoprim | Trimethoprim Trimethoprim may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Nifedipine | Nifedipine Azacitidine may decrease the excretion rate of Nifedipine which could result in a higher serum level. |
Timolol | Timolol Timolol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Verapamil | Verapamil Verapamil may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Pindolol | Pindolol Azacitidine may decrease the excretion rate of Pindolol which could result in a higher serum level. |
Cisplatin Injection | Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Azacitidine. |
Diflunisal | Diflunisal Diflunisal may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Piroxicam | Piroxicam Piroxicam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Bumetanide | Bumetanide Bumetanide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Streptozocin | Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Azacitidine. |
Etoposide | Etoposide The risk or severity of adverse effects can be increased when Etoposide is combined with Azacitidine. |
Glipizide | Glipizide Azacitidine may decrease the excretion rate of Glipizide which could result in a higher serum level. |
Indapamide | Indapamide Indapamide may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy. |
Amoxicillin | Amoxicillin Azacitidine may decrease the excretion rate of Amoxicillin which could result in a higher serum level. |
Oxacillin Injection | Oxacillin Injection Oxacillin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Pentoxifylline | Pentoxifylline Pentoxifylline may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Pentamidine Injection | Pentamidine Injection Pentamidine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ceftriaxone Injection | Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Labetalol | Labetalol Labetalol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Auranofin | Auranofin Azacitidine may decrease the excretion rate of Auranofin which could result in a higher serum level. |
Leuprolide Injection | Leuprolide Injection Leuprolide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Gemfibrozil | Gemfibrozil Azacitidine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level. |
Dipivefrin Ophthalmic | Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ceftazidime Injection | Ceftazidime Injection Ceftazidime may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ketoprofen | Ketoprofen Ketoprofen may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefotetan Injection | Cefotetan Injection Cefotetan may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Flurbiprofen | Flurbiprofen Flurbiprofen may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Aztreonam Injection | Aztreonam Injection Aztreonam may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Buspirone | Buspirone Buspirone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Ciprofloxacin | Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Mesalamine | Mesalamine Mesalazine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Diclofenac | Diclofenac Diclofenac may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Interferon Alfa-2b Injection | Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Azacitidine. |
Clozapine | Clozapine The risk or severity of neutropenia can be increased when Azacitidine is combined with Clozapine. |
Estazolam | Estazolam Azacitidine may decrease the excretion rate of Estazolam which could result in a higher serum level. |
Idarubicin | Idarubicin The risk or severity of adverse effects can be increased when Azacitidine is combined with Idarubicin. |
Didanosine | Didanosine Didanosine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Fludarabine Injection | Fludarabine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Fludarabine. |
Pentostatin Injection | Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Azacitidine. |
Etodolac | Etodolac Etodolac may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Fosinopril | Fosinopril Fosinopril may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Nabumetone | Nabumetone Nabumetone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Epoetin Alfa, Injection | Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Azacitidine. |
Teniposide Injection | Teniposide Injection The risk or severity of adverse effects can be increased when Teniposide is combined with Azacitidine. |
Lisinopril | Lisinopril Lisinopril may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Oxaprozin | Oxaprozin Oxaprozin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Bisoprolol | Bisoprolol Bisoprolol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Isradipine | Isradipine Isradipine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Venlafaxine | Venlafaxine Venlafaxine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Fluvoxamine | Fluvoxamine Fluvoxamine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Nefazodone | Nefazodone Azacitidine may decrease the excretion rate of Nefazodone which could result in a higher serum level. |
Lamotrigine | Lamotrigine Lamotrigine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Valacyclovir | Valacyclovir Valaciclovir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tramadol | Tramadol Tramadol may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Vinorelbine Injection | Vinorelbine Injection The risk or severity of adverse effects can be increased when Vinorelbine is combined with Azacitidine. |
Carboplatin Injection | Carboplatin Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Carboplatin. |
Ifosfamide Injection | Ifosfamide Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Ifosfamide. |
Pegaspargase Injection | Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Azacitidine. |
Bupropion | Bupropion Azacitidine may decrease the excretion rate of Bupropion which could result in a higher serum level. |
Ticlopidine | Ticlopidine Ticlopidine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Metformin | Metformin Metformin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Dalteparin Injection | Dalteparin Injection The risk or severity of bleeding can be increased when Dalteparin is combined with Azacitidine. |
Nisoldipine | Nisoldipine Nisoldipine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Lamivudine | Lamivudine Lamivudine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Acarbose | Acarbose Acarbose may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Gemcitabine Injection | Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Azacitidine. |
Docetaxel Injection | Docetaxel Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Docetaxel. |
Cidofovir Injection | Cidofovir Injection Cidofovir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Meropenem Injection | Meropenem Injection Meropenem may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Clomipramine | Clomipramine Azacitidine may decrease the excretion rate of Clomipramine which could result in a higher serum level. |
Fosfomycin | Fosfomycin Fosfomycin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Topiramate | Topiramate Topiramate may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Pramipexole | Pramipexole Pramipexole may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Nilutamide | Nilutamide Nilutamide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Flutamide | Flutamide Flutamide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tamsulosin | Tamsulosin Tamsulosin may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Quetiapine | Quetiapine Azacitidine may decrease the excretion rate of Quetiapine which could result in a higher serum level. |
Cefepime Injection | Cefepime Injection Cefepime may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefprozil | Cefprozil Cefprozil may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cefpodoxime | Cefpodoxime Cefpodoxime may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Cetirizine | Cetirizine Cetirizine may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tolcapone | Tolcapone Tolcapone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Capecitabine | Capecitabine The risk or severity of adverse effects can be increased when Azacitidine is combined with Capecitabine. |
Abacavir | Abacavir Azacitidine may decrease the excretion rate of Abacavir which could result in a higher serum level. |
Trastuzumab Injection | Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Azacitidine. |
Celecoxib | Celecoxib Celecoxib may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Rosiglitazone | Rosiglitazone Rosiglitazone may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Tolterodine | Tolterodine Azacitidine may decrease the excretion rate of Tolterodine which could result in a higher serum level. |
Thalidomide | Thalidomide The risk or severity of adverse effects can be increased when Azacitidine is combined with Thalidomide. |
Oseltamivir | Oseltamivir Oseltamivir may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Balsalazide | Balsalazide Balsalazide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Nateglinide | Nateglinide Nateglinide may decrease the excretion rate of Azacitidine which could result in a higher serum level. |
Rabeprazole | Rabeprazole Azacitidine may decrease the excretion rate of Rabeprazole which could result in a higher serum level. |
Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists